Researchers have found that the budding yeast is an acceptable model system to study KP1019, an anti-cancer drug that uses ruthenium, a rare metal, a new study found.
Researchers have found that the budding yeast is an acceptable model system to study KP1019, an anti-cancer drug that uses ruthenium, a rare metal, a new study found.